Granuloma faciale
Template:DiseaseDisorder infobox
|
WikiDoc Resources for Granuloma faciale |
|
Articles |
|---|
|
Most recent articles on Granuloma faciale Most cited articles on Granuloma faciale |
|
Media |
|
Powerpoint slides on Granuloma faciale |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Granuloma faciale |
|
Clinical Trials |
|
Ongoing Trials on Granuloma faciale at Clinical Trials.gov Trial results on Granuloma faciale Clinical Trials on Granuloma faciale at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Granuloma faciale NICE Guidance on Granuloma faciale
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Granuloma faciale Discussion groups on Granuloma faciale Patient Handouts on Granuloma faciale Directions to Hospitals Treating Granuloma faciale Risk calculators and risk factors for Granuloma faciale
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Granuloma faciale |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Granuloma faciale (GF) is an uncommon benign chronic skin disease of unknown origin characterized by single or multiple cutaneous nodules, usually occurring over the face. Occasionally, extrafacial involvement is noted, most often on sun-exposed areas.
History
Lever and Leeper first recognized GF as a distinct entity in 1950. Pinkus' group suggested the name granuloma faciale that same year.
Differential diagnosis
The disease mimics many other dermatoses and can be confused with conditions, such as sarcoidosis, discoid lupus erythematosus, mycosis fungoides, and fixed drug eruption.